Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.560
+0.100 (6.85%)
At close: Oct 9, 2026, 4:00 PM EDT
1.530
-0.030 (-1.92%)
After-hours: Oct 9, 2026, 7:55 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $50.62 million as of October 9, 2026. It is the 30,355th most valuable company in the world and the 4,664th biggest in the United States. Its market cap has decreased by 11.79% in one year.
Market Cap
50.62M
Enterprise Value
118.33M
1-Year Change
-11.79%
Global Rank
Country Rank
#4,664 United States
Category
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $50.62M, a decrease of -85.63%. That is a compound annual growth rate of -23.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 50.62M | 60.14% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edesa Biotech | 52.56M |
| ImageneBio | 52.39M |
| Annovis Bio | 51.55M |
| Serina Therapeutics | 51.31M |
| eXoZymes | 51.23M |
| Apollomics | 50.92M |
| INmune Bio | 50.79M |
| Dogwood Therapeutics | 49.46M |